May 21, 2019
Karen Midthun, M.D., Joins Greenleaf Health
Firm Announces Dr. Midthun as Principal, Drug and Biological Products WASHINGTON–(BUSINESS WIRE)–Greenleaf Health, Inc. (Greenleaf), a leading Food and Drug…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
May 21, 2019
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company, today announced it will be presenting…
May 21, 2019
Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research
Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence generation SAN…
May 21, 2019
US Breast Cancer Drug Market 2019-2025 Opportunity: $ 20 Billion
DUBLIN–(BUSINESS WIRE)–The “US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025” drug pipelines has been added to…
May 21, 2019
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
Acquisition Includes Novel Late-Stage Renal Cell Carcinoma Candidate, PT2977 KENILWORTH, N.J. & DALLAS–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;–Merck (NYSE:…
May 21, 2019
LineaRx Anticipates Expansion in Diagnostics Market via Follow-on Order and New Linear DNA Amplicons for Additional Assay
Shipments for Follow-on Order Under Existing Supply Agreement Will Commence This Quarter STONY BROOK, N.Y.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24apdn&src=ctag" target="_blank"gt;$apdnlt;/agt; lt;a href="https://twitter.com/hashtag/PCR?src=hash"…
May 21, 2019
EXUMA Biotechnology’s Affiliate Shanghai PerHum Therapeutics Announces Preliminary Results of Two First-in-Human Solid Tumor CAR-T Products
Data Supports Continued Dose Escalation and Further Investigation in Metastatic Renal Cell Carcinoma (mRCC) MAINZ, Germany–(BUSINESS WIRE)–EXUMA Biotechnology and affiliate…
May 21, 2019
Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration
Completion of Gene-to-Lead phase for first discovery project targeting METTL3/METTL14 complex NEW YORK & LEIDEN, Netherlands–(BUSINESS WIRE)–Gotham Therapeutics, a biotechnology…
May 21, 2019
First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy
ZURICH–(BUSINESS WIRE)–Regulatory News: Vifor Pharma today announced that treatment of the first patient in their global phase-IIIb DIAMOND study has…
May 21, 2019
Imago BioSciences to Present First Clinical Data for IMG-7289 At 24th Congress of the European Hematology Association
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EHA24?src=hash" target="_blank"gt;#EHA24lt;/agt;–Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced that…